Company intelligence / Profile preview

ZophIA

Ownership: Private
Development stage: Preclinical

Overview

ZophIA has developed an artificial intelligence and mathematics-powered tool that analyzes patient speech to assist healthcare professionals in diagnosing mental disorders. The solution aims to address the high demand for mental health services and the shortage of specialist doctors by supporting more efficient and personalized care. No published clinical trial results are available; the product appears to be in early commercial or pilot deployment.

Therapeutic areas: Psychiatry
Modalities: DeviceNon-pharmacological therapyArtificial intelligence-based diagnostic tool (not a drug/biologic modality)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on ZophIA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZophIA.

Explore the full profile